Market Research Logo

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

The global women’s health diagnostics market is projected to reach USD 36.64 billion by 2021, growing at a CAGR of around 7.9% during the forecast period. Growth in this market can be attributed to a number of factors such as high prevalence of infectious diseases in women, rising incidence of chronic and lifestyle-related disorders and increasing awareness about fertility testing in women and initiatives taken by government and health organizations. Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, high cost of diagnostic solutions and lack of trained laboratory technicians are some of the factors restraining the growth of this market.

The women health diagnostics market in this report is segmented by application and end users. Based on application, the market is segmented into osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease (STD) testing, and ultrasound. The osteoporosis segment is further divided into bone densitometry and in vitro blood tests. The ovarian cancer segment is divided into tumor marker tests, diagnostic imaging tests and others. The cervical cancer segment is sub segmented into PAP smear testing and HPV testing. The breast cancer testing segment is further divided into mammography systems, tumor marker tests, blood chemistries & blood cell count tests, biopsies, and other diagnostic imaging tests. Pregnancy and fertility testing market is sub segmented into lab-based testing, pregnancy self-test and ovulation prediction kits, ovulation prediction kits, fertility monitors and thermometers. The prenatal genetic screening & carrier testing segment is further divided into cystic fibrosis, Down syndrome and Edward syndrome, TORCH infections and others (fragile x-syndrome & tay-sachs diseases). Further on, the infectious disease testing market segment is sub segmented into methicillin-resistant staphylococcus aurea (MRSA), urinary tract infections (vaginal pH & vaginitis), hepatitis, tuberculosis and streptococcus testing. The sexually transmitted disease testing segment comprises Chlamydia Trachomatis and Neisseria Gonorrohoeae testing, HIV testing and other STD testing. The ultrasound segment covers breast imaging and ob/gyn imaging. In 2015, the breast cancer testing product segment accounted for the largest share of the women health diagnostics market. This market is primarily driven by the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques. Based on end user, the women health diagnostics market is segmented into three segments, namely, hospitals & clinics, home care, and diagnostic & imaging centers.

In 2015, North America accounted for the largest share to the global women health diagnostics market, followed by Europe, Asia-Pacific, and the RoW. Growth in the North American market is largely driven by the increasing prevalence of cancer among women in this region, the presence of a large number of players and their increasing efforts to expand presence in North America. Furthermore, the increasing prevalence of cancer among women and increasing demand for fertility testing kits and monitors in North American countries is augmenting the demand for diagnostic tests.

Some of the major players in the women health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

Research Coverage
Detailed insights on all the submarkets, based on application (osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound), this can help market players to identify high growth segments in the women’s health diagnostics market.

The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.

Key insights and market sizing for the different end users of the women health diagnostics market namely, hospitals & clinics, home healthcare, and diagnostic & imaging centers.

Country-wise market size and forecast for all the sub segments. Thus, not only the high growth application and end user areas; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years.

It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report
The report will augment established firms as well as new entrants/smaller firms to measure the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on product portfolios offered by top players in the women health diagnostics market. The report analyzes the women’s health diagnostics market by application, and end user across all regions
Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the women health diagnostics market
Market Development: Comprehensive information on the lucrative emerging markets by application, end user, and region
Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the women health diagnostics market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and distribution networks, of leading players in the women health diagnostics market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • WOMEN'S HEALTH DIAGNOSTICS: MARKET OVERVIEW
    • ASIA-PACIFIC: PREGNANCY AND FERTILITY TESTING MARKET, BY PRODUCT TYPE (2015)
    • GEOGRAPHIC SNAPSHOT OF THE WOMEN'S HEALTH DIAGNOSTICS MARKET
    • GEOGRAPGIC MIX: WOMEN'S HEALTH DIAGNOSTICS MARKET
    • WOMEN'S HEALTH DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
  • MARKET OVERVIEW
    • INTRODUCTION
    • KEY MARKET DYNAMICS
      • KEY MARKET DRIVERS
        • Table RISING INCIDENCE OF CHRONIC AND LIFESTYLE-RELATED DISORDERS IN WOMEN TO DRIVE MARKET GROWTH
      • KEY MARKET RESTRAINTS
        • Table HIGH COST OF DIAGNOSTIC IMAGING SYSTEMS AND PROCEDURES AFFECTING THE RATE OF ADOPTION IN EMERGING MARKETS
      • KEY MARKET OPPORTUNITIES
        • Table IMPROVING HEALTHCARE INFRASTRUCTURE IN EMERGING MARKETS TO PLAY A MAJOR ROLE IN THE GROWTH OF THE WOMEN'S HEALTH DIAGNOSTICS MARKET
      • KEY MARKET CHALLENGES
        • Table STRINGENT REGULATORY GUIDELINES POSE A CHALLENGE FOR DIAGNOSTIC DEVICE MANUFACTURERS
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • INDUSTRY TRENDS
      • GROWING FOCUS ON MICROFLUIDICS- AND NANOTECHNOLOGYBASED POC DEVICES FOR DIAGNOSTICS
      • RISING FOCUS OF MARKET PLAYERS ON PREGNANCY AND FERTILITY ISSUES IN EMERGING REGIONS
    • CLINICAL TRIALS ASSESSMENT FOR BREAST CANCER DIAGNOSTICS
  • WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table WOMEN'S HEALTH DIAGNOSTICS MARKET: PRODUCT PORTFOLIO ANALYSIS
      • Table GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
    • OSTEOPOROSIS TESTING
      • Table GLOBAL OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL OSTEOPOROSIS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • BONE DENSITOMETRY
        • Table GLOBAL BONE DENSITOMETRY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • IN VITRO BLOOD TESTS
        • Table GLOBAL IN VITRO BLOOD TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • BREAST CANCER TESTING
      • Table GLOBAL BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL BREAST CANCER TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • MAMMOGRAPHY
        • Table GLOBAL MAMMOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • BREAST CANCER TUMOR MARKER TESTS
        • Table GLOBAL BREAST CANCER TUMOR MARKER TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS
        • Table GLOBAL BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • BIOPSIES
        • Table GLOBAL BIOPSIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • OTHER DIAGNOSTIC IMAGING TESTS
        • Table GLOBAL OTHER DIAGNOSTIC IMAGING TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • OVARIAN CANCER TESTING
      • Table GLOBAL OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL OVARIAN CANCER TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • OVARIAN CANCER TUMOR MARKER TESTS
        • Table GLOBAL OVARIAN CANCER TUMOR MARKER TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • DIAGNOSTIC IMAGING TESTS
        • Table GLOBAL DIAGNOSTIC IMAGING TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • OTHER TESTS
        • Table GLOBAL OTHER OVARIAN CANCER TESTS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • CERVICAL CANCER TESTING
      • Table GLOBAL CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL CERVICAL CANCER TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • PAP SMEAR
        • Table GLOBAL PAP SMEAR MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • HPV TESTING
        • Table GLOBAL HPV TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • PREGNANCY AND FERTILITY TESTING
      • Table GLOBAL PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • LAB-BASED TESTING
        • Table GLOBAL LAB-BASED TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • PREGNANCY TESTING AND OVULATION PREDICTION KITS
        • Table GLOBAL PREGNANCY AND OVULATION PREDICTION KITS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • FERTILITY MONITORS
        • Table GLOBAL FERTILITY MONITORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • PRENATAL GENETIC SCREENING AND CARRIER TESTING
      • Table GLOBAL PRENATAL GENETIC SCREENING AND CARRIER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL PRENATAL GENETIC SCREENING AND CARRIER TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • CYSTIC FIBROSIS
        • Table GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • DOWN SYNDROME AND EDWARDS SYNDROME
        • Table GLOBAL DOWN SYNDROME AND EDWARDS SYNDROME MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • TORCH INFECTIONS
        • Table GLOBAL TORCH INFECTIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • OTHER DISEASES
        • Table GLOBAL OTHER DISEASES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • INFECTIOUS DISEASE TESTING
      • Table GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • MRSA TESTING
        • Table GLOBAL MRSA TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS)
        • Table GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • HEPATITIS TESTING
        • Table GLOBAL HEPATITIS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • TUBERCULOSIS TESTING
        • Table GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • OTHER INFECTIOUS DISEASES
        • Table GLOBAL OTHER INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • SEXUALLY TRANSMITTED DISEASE TESTING
      • Table GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING
        • Table GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • HIV TESTING
        • Table GLOBAL HIV TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • OTHER SEXUALLY TRANSMITTED DISEASES
        • Table GLOBAL OTHER SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • ULTRASOUND TESTS
      • Table GLOBAL ULTRASOUND TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL ULTRASOUND TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • BREAST IMAGING
        • Table GLOBAL BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • OB/GYN IMAGING
        • Table GLOBAL OB/GYN MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • HOSPITALS AND CLINICS
      • Table GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE FOR HOSPITALS AND CLINICS, BY COUNTRY, 2014-2021 (USD MILLION)
    • DIAGNOSTIC AND IMAGING CENTERS
      • Table GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
    • HOME CARE
      • Table GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE FOR HOME CARE, BY COUNTRY, 2014-2021 (USD MILLION)
  • WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
      • Table NORTH AMERICA: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
      • Table NORTH AMERICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
      • Table NORTH AMERICA: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.S.
        • Table U.S. : WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table U.S. : BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S. : OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S. : INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table U.S. : PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S. : ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
        • Table U.S. : SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table U.S. : PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
        • Table U.S. : CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
        • Table U.S. : OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S. : WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CANADA
        • Table CANADA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table CANADA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table CANADA : PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
        • Table CANADA : SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table CANADA : PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
        • Table CANADA : CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
        • Table CANADA: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA : WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • EUROPE
      • Table EUROPE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table EUROPE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table EUROPE: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table EUROPE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table EUROPE: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE,2014-2021 (USD MILLION)
      • Table EUROPE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
      • Table EUROPE: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
      • Table EUROPE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • GERMANY
        • Table GERMANY : WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table GERMANY: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table GERMANY: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table GERMANY: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE,2014-2021 (USD MILLION)
        • Table GERMANY: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.K.
        • Table U.K.: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table U.K: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.K: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.K: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table U.K: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.K: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table U.K: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table U.K: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table U.K: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
        • Table U.K: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
        • Table U.K: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • FRANCE
        • Table FRANCE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table FRANCE: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table FRANCE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table FRANCE : INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table FRANCE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table FRANCE: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table FRANCE: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table FRANCE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE,2014-2021 (USD MILLION)
        • Table FRANCE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
        • Table FRANCE: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
        • Table FRANCE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • ITALY
        • Table ITALY : WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table ITALY: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ITALY: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ITALY : INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table ITALY: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ITALY: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table ITALY: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table ITALY: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table ITALY: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
        • Table ITALY: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION)
        • Table ITALY: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • SPAIN
        • Table SPAIN: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table SPAIN: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table SPAIN: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table SPAIN: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table SPAIN : PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table SPAIN : ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
        • Table SPAIN : SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table SPAIN : PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
        • Table SPAIN : CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
        • Table SPAIN : OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table SPAIN : WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table ROE: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROE: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table ROE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROE: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
        • Table ROE: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table ROE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
        • Table ROE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
        • Table ROE: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROE: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • ASIA-PACIFIC
      • Table APAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table APAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
      • Table APAC: BREAST CANCER TESTING, BY TYPE, (USD MILLION)
      • Table APAC: OSTEOPOROSIS TESTING, BY TYPE, 2014-2021 (USD MILLION)
      • Table APAC: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table APAC: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table APAC: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table APAC: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
      • Table APAC: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
      • Table APAC: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table APAC: OVARIAN CANCER MARKET SIZE, BY TESTING, 2014-2021 (USD MILLION)
      • Table APAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • JAPAN
        • Table JAPAN: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
        • Table JAPAN: BREAST CANCER TESTING, BY TYPE, 2014-2021 (USD MILLION)
        • Table JAPAN: OSTEOPOROSIS TESTING, BY TYPE, 2014-2021 (USD MILLION)
        • Table JAPAN: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021, (USD MILLION)
        • Table JAPAN: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
        • Table JAPAN: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table JAPAN: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table JAPAN: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table JAPAN: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table JAPAN: OVARIAN CANCER MARKET SIZE, BY TESTING, 2014-2021 (USD MILLION)
        • Table JAPAN: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CHINA
        • Table CHINA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table CHINA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CHINA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CHINA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table CHINA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CHINA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
        • Table CHINA: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table CHINA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
        • Table CHINA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
        • Table CHINA: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CHINA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • INDIA
        • Table INDIA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
        • Table INDIA: BREAST CANCER TESTING, BY TYPE, 2014-2021 (USD MILLION)
        • Table INDIA: OSTEOPOROSIS TESTING, BY TYPE, 2014-2021 (USD MILLION)
        • Table INDIA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table INDIA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table INDIA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table INDIA: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table INDIA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
        • Table INDIA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table INDIA: OVARIAN CANCER MARKET SIZE, BY TESTING, 2014-2021 (USD MILLION)
        • Table INDIA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • REST OF ASIA-PACIFIC
        • Table ROAPAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
        • Table ROAPAC: BREAST CANCER TESTING, BY TYPE, (USD MILLION)
        • Table ROAPAC: OSTEOPOROSIS TESTING, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROAPAC: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table ROAPAC: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
        • Table ROAPAC: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table ROAPAC: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table ROAPAC: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table ROAPAC: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROAPAC: OVARIAN CANCER MARKET SIZE, BY TESTING, 2014-2021, (USD MILLION)
        • Table ROAPAC: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER (USD MILLION)
    • ROW
      • Table ROW: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ROW: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table ROW: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table ROW: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
      • Table ROW: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
      • Table ROW: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
      • Table ROW: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
      • Table ROW: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • LATIN AMERICA
        • Table LATIN AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021, (USD MILLION)
        • Table LATIN AMERICA: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021, (USD MILLION)
        • Table LATIN AMERICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021, (USD MILLION)
        • Table LATIN AMERICA: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • MIDDLE EAST & AFRICA
        • Table MIDDLE EAST & AFRICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: OVARIAN CANCER MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
      • Table GROWTH STRATEGY MATRIX (2013-2016)
    • STRATEGIC BENCHMARKING
    • COMPETITIVE SITUATIONS AND TRENDS
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES, 2013-2016
      • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
        • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2013-2016
      • REGULATORY APPROVALS
        • Table REGULATORY APPROVALS, 2013-2016
  • COMPANY PROFILES
    • SIEMENS AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • QUEST DIAGNOSTICS INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • HOLOGIC, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • F. HOFFMANN-LA ROCHE AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • PERKINELMER INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ALERE INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GE HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BIOMÉRIEUX SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • KONINKLIJKE PHILIPS N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report